116 related articles for article (PubMed ID: 12846549)
1. Age-related changes of the [11C]CFT binding to the striatal dopamine transporters in the Fischer 344 rats: a PET study.
Kawamura K; Oda K; Ishiwata K
Ann Nucl Med; 2003 May; 17(3):249-53. PubMed ID: 12846549
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
[TBL] [Abstract][Full Text] [Related]
3. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
[TBL] [Abstract][Full Text] [Related]
4. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
[TBL] [Abstract][Full Text] [Related]
5. [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.
Haaparanta M; Bergman J; Laakso A; Hietala J; Solin O
Synapse; 1996 Aug; 23(4):321-7. PubMed ID: 8855517
[TBL] [Abstract][Full Text] [Related]
6. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
Ouchi Y; Yoshikawa E; Okada H; Futatsubashi M; Sekine Y; Iyo M; Sakamoto M
Ann Neurol; 1999 May; 45(5):601-10. PubMed ID: 10319882
[TBL] [Abstract][Full Text] [Related]
7. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
[TBL] [Abstract][Full Text] [Related]
9. Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography.
Rinne JO; Sahlberg N; Ruottinen H; Någren K; Lehikoinen P
Neurology; 1998 Jan; 50(1):152-6. PubMed ID: 9443472
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ
Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
[TBL] [Abstract][Full Text] [Related]
13. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
14. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
Laakso A; Bergman J; Haaparanta M; Vilkman H; Solin O; Syvälahti E; Hietala J
Schizophr Res; 2001 Oct; 52(1-2):115-20. PubMed ID: 11595398
[TBL] [Abstract][Full Text] [Related]
15. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J
J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345
[TBL] [Abstract][Full Text] [Related]
16. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.
Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N; Nakanishi S
Brain Res; 1999 Dec; 849(1-2):85-96. PubMed ID: 10592290
[TBL] [Abstract][Full Text] [Related]
17. Spermine interacts with cocaine binding sites on dopamine transporters.
Ritz MC; Mantione CR; London ED
Psychopharmacology (Berl); 1994 Feb; 114(1):47-52. PubMed ID: 7846207
[TBL] [Abstract][Full Text] [Related]
18. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia.
Rinne JO; Laine M; Kaasinen V; Norvasuo-Heilä MK; Någren K; Helenius H
Neurology; 2002 May; 58(10):1489-93. PubMed ID: 12034784
[TBL] [Abstract][Full Text] [Related]
20. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
